Lauren Argo
Acute Care · Springfield, MONPI 1679049480
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.0% of the total across 179 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 20.2% — the pattern of someone who eats at a lot of different presentations. Among acute care clinicians in MO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 179 payments — averaging $18.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$674
- AbbVie$576
- Vanda Pharmaceuticals Inc.$393
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$289
- Novo Nordisk$282
- AstraZeneca$153
- plus $964 from 14 others
What the payments were for
- Food & beverage$3,29999%
- Education$321%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 41 | $674 |
| AbbVie | 31 | $576 |
| Vanda Pharmaceuticals Inc. | 16 | $393 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 15 | $289 |
| Novo Nordisk | 15 | $282 |
| AstraZeneca | 10 | $153 |
| Otsuka America Pharmaceutical, Inc. | 7 | $143 |
| Organon | 3 | $123 |
| Abbott | 4 | $85 |
| GSK | 5 | $83 |
| Lundbeck LLC | 5 | $77 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $70 |
| Novartis | 4 | $66 |
| Boehringer Ingelheim | 4 | $55 |
| Exact Sciences | 3 | $54 |
| Pfizer | 3 | $54 |
| Avanir Pharmaceuticals, Inc. | 3 | $46 |
| Astellas Pharma US Inc | 2 | $43 |
| Globus Medical | 1 | $36 |
| Mylan Specialty L.p. | 2 | $28 |
How this compares
$3,331 in reported general payments places this provider in the 90th percentile of 272 acute care providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 36 | $48,345 |
| JardianceEmpagliflozin | 64 | $45,477 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 54 | $42,431 |
| TrulicityDulaglutide | 43 | $40,851 |
| EliquisApixaban | 40 | $36,211 |
| FarxigaDapagliflozin Propanediol | 22 | $24,606 |
| VraylarCariprazine Hcl | 12 | $16,932 |
| MyrbetriqMirabegron | 11 | $11,281 |
| SymbicortBudesonide/Formoterol Fumarate | 28 | $9,290 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 14 | $8,861 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 12 | $6,681 |
| Breo ElliptaFluticasone/Vilanterol | 14 | $6,515 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 11 | $5,289 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 146 | $3,576 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 18 | $2,657 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta | $83 | $55,62780 claims |
| Boehringer IngelheimJardiance, Combivent Respimat | $55 | $50,76575 claims |
| Novo NordiskOzempic | $282 | $48,34536 claims |
| AstraZenecaFarxiga, Symbicort, Breztri Aerosphere | $153 | $42,75764 claims |
| Lilly USA, LLCTrulicity | $674 | $40,85143 claims |
| PfizerEliquis | $54 | $36,21140 claims |
| AbbVieVraylar, Synthroid | $576 | $17,99523 claims |
| Astellas Pharma US IncMyrbetriq | $43 | $11,28111 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 272 acute care providers in Missouri.
Other acute care in Springfield
- Rebekah PierceSpringfield$3K
- Melody RussellSpringfield$2K
- Stephanie FranklinSpringfield$2K
- Andria OrtizSpringfield$2K
- Heather DearingSpringfield$1K
- Hanna KlineSpringfield$1K
- Denise MooreSpringfield$1K
- Molly CahillKansas City$22K
- Kristin PressChesterfield$14K
- Sarah HeaveyKansas City$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.